{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/prostatitis-acute/how-this-topic-was-developed/evidence-exclusion-criteria/","result":{"pageContext":{"chapter":{"id":"63ca9076-27d4-5254-9eda-bcbb43177d95","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria","depth":2,"htmlHeader":"<!-- begin field 954d88e3-e421-40c0-abba-a7f201891dc7 --><h2>Evidence exclusion criteria</h2><!-- end field 954d88e3-e421-40c0-abba-a7f201891dc7 -->","summary":null,"htmlStringContent":"<!-- begin item e6b06a2e-0a55-4e12-a209-a7f20187a3cf --><!-- begin field 2150d6e1-1238-42bb-ad59-a7f201891dc7 --><h2>Our policy</h2><!-- end field 2150d6e1-1238-42bb-ad59-a7f201891dc7 --><!-- begin field 8756808d-b805-499e-91b8-a7f201891dc7 --><p>Scoping a literature search, and reviewing the evidence for CKS is a methodical and systematic process that is carried out by the lead clinical author for each topic. Relevant evidence is gathered in order that the clinical author can make fully informed decisions and recommendations. It is important to note that some evidence may be excluded for a variety of reasons. These reasons may be applied across all CKS topics or may be specific to a given topic.</p><p>Studies identified during literature searches are reviewed to identify the most appropriate information to author a CKS topic, ensuring any recommendations are based on the best evidence. We use the principles of the GRADE and PICOT approaches to assess the quality of published research. We use the principles of AGREE II to assess the quality of published guidelines.</p><!-- end field 8756808d-b805-499e-91b8-a7f201891dc7 --><!-- begin field e270d3e5-c0c1-4adf-908b-a7f201891dc7 --><h2>Standard exclusions for scoping literature:</h2><!-- end field e270d3e5-c0c1-4adf-908b-a7f201891dc7 --><!-- begin field bd43b839-b539-45a0-aac2-a7f201891dc7 --><ul><li>Animal studies</li><li>Original research is not written in English</li></ul><!-- end field bd43b839-b539-45a0-aac2-a7f201891dc7 --><!-- begin field 638dd460-7572-4c7d-966b-a7f201891dc7 --><h2>Possible exclusions for reviewed literature:</h2><!-- end field 638dd460-7572-4c7d-966b-a7f201891dc7 --><!-- begin field d14cdce8-80e8-4312-94dc-a7f201891dc7 --><ul><li>Sample size too small or study underpowered</li><li>Bias evident or promotional literature</li><li>Population not relevant</li><li>Intervention/treatment not relevant</li><li>Outcomes not relevant</li><li>Outcomes have no clear evidence of clinical effectiveness</li><li>Setting not relevant</li><li>Not relevant to UK</li><li>Incorrect study type</li><li>Review article</li><li>Duplicate reference</li></ul><!-- end field d14cdce8-80e8-4312-94dc-a7f201891dc7 --><!-- end item e6b06a2e-0a55-4e12-a209-a7f20187a3cf -->","topic":{"id":"73f0b35c-c49b-5f10-bb40-54ecdda0c994","topicId":"e7655eee-79f9-435e-b34e-7e3dc9576eb5","topicName":"Prostatitis - acute","slug":"prostatitis-acute","lastRevised":"Last revised in November 2020","chapters":[{"id":"8803a04f-6c62-5033-ac75-2e0987df1dd9","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"23265380-0c8c-51f6-984e-87cbf6e27684","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"7f11e55f-ca93-5c30-86f8-fa21b370c650","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"aa21e1cb-1af6-5deb-b54b-9cb7a12a8a11","slug":"changes","fullItemName":"Changes"},{"id":"bc4d0c33-79f0-5fe0-8655-d9dbf99bbcf5","slug":"update","fullItemName":"Update"}]},{"id":"e29f027b-46a8-5ac6-b1b7-d063f673588e","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"e0a59bba-34f6-512a-b3f6-19ba509165b0","slug":"goals","fullItemName":"Goals"},{"id":"b99f36b6-4383-55b0-8d6f-72dfeed4d249","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"0629bcf7-67ce-5175-893c-bb0e770c16c1","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"6da14859-d882-5bd2-b686-021dc2ab43ca","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"90fb5a5f-3ae5-53d9-b871-bf93c899f97c","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"a78a1b88-9559-551a-880f-736efedb2497","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"c8ae728c-472f-509a-add8-39034e05aff0","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"816a1fba-211e-520e-87c1-c47a23e06dd3","slug":"definition","fullItemName":"Definition"},{"id":"42efdea9-f709-5243-8b5c-a2b75dbbba5f","slug":"causes","fullItemName":"Causes"},{"id":"9713a2ac-cc24-5443-9756-3e59fbcf65b8","slug":"prevalence","fullItemName":"Prevalence"},{"id":"d981ad36-33da-56db-bb45-f12d69fe5543","slug":"prognosis","fullItemName":"Prognosis"},{"id":"5b0439a7-9599-542f-b2b2-51d20cc566f2","slug":"complications","fullItemName":"Complications"}]},{"id":"6553966d-798f-5d17-bcd0-6f62f2f8b5bd","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"d539bec4-2427-585f-a83c-db984fc0d801","slug":"suspecting-acute-prostatitis","fullItemName":"Suspecting acute prostatitis"},{"id":"d1e691e6-d634-508e-a5c1-62018b5b24be","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"2e7dc7c5-dc32-59bf-9021-54b838ce5a9b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"398acafd-0ba3-5cf1-8c9c-8d2ccca863ae","fullItemName":"Management","slug":"management","subChapters":[{"id":"8c56415b-f5bc-5fc1-b859-13b369ee963d","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"50977f3d-5737-50f5-9c23-c4a03b4539cf","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"c6f0cb41-8824-5f6b-9b63-19a56232237a","slug":"ciprofloxacin","fullItemName":"Ciprofloxacin"},{"id":"161382aa-bad2-5c17-9d1c-59f978dd6a83","slug":"ofloxacin","fullItemName":"Ofloxacin"},{"id":"6aee14ab-550d-5bdd-b0e4-d2febce26f7a","slug":"trimethoprim","fullItemName":"Trimethoprim"},{"id":"7fc380fc-24a6-5224-9d35-019f77e2d24e","slug":"levofloxacin","fullItemName":"Levofloxacin"},{"id":"fc84b330-890f-5ebf-b2cd-5724765b85a8","slug":"co-trimoxazole","fullItemName":"Co-trimoxazole"}]},{"id":"c4981733-d5d6-5190-b43d-7cdee7ac825c","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"137ffbc9-e5c4-5f58-bfc1-4d3afb883356","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"5f07d427-7c9b-521d-ba7a-1a7bc564f48d","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"05f5c8e4-6073-506c-909a-cef5c3cf622c","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"63ca9076-27d4-5254-9eda-bcbb43177d95","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"ff474396-1f31-58cd-b153-976c3894cafd","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"be6b66c2-c9cc-5d52-99dd-044e49dadfb0","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"9b5aeabb-1902-5659-8e0b-625f567b86e0","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"137ffbc9-e5c4-5f58-bfc1-4d3afb883356","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}